Premium
Role of thioridazine in unexplained infertility
Author(s) -
Sharma J.B.,
Sharma S.
Publication year - 1992
Publication title -
international journal of gynecology and obstetrics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.895
H-Index - 97
eISSN - 1879-3479
pISSN - 0020-7292
DOI - 10.1016/0020-7292(92)90975-o
Subject(s) - medicine , thioridazine , infertility , incidence (geometry) , placebo , pregnancy , gynecology , obstetrics , unexplained infertility , chlorpromazine , physics , alternative medicine , pathology , biology , optics , genetics
A total of 452 women with unexplained infertility were selected for the present study. From them 310 women were put on thioridazine tablet (5 mg), 1 h after dinner from the 8th day of the menstrual cycle to the 18th day in each cycle. Coitus was advised about 1–2 h after the drug intake and proper posture was advised to the patients. The other 142 patients were given placebo therapy. Patients were followed up for pregnancy for 1 year which was confirmed by ultrasonographic examination. Ninety‐four patients (30.2%) in the study group conceived in contrast to 22 (15.42%) in the control group (P < 0.001). Incidence of abortions, congenital malformations and perinatal mortality and mode of delivery were not significantly different in the two groups. Thioridazine due to anxiolytic effect in low dosage appears to be promising in the treatment of unexplained infertility.